Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ASPI
ASPI logo

ASPI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy ASP Isotopes Inc (ASPI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.290
1 Day change
4.38%
52 Week Range
14.490
Analysis Updated At
2026/04/02
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

ASP Isotopes Inc (ASPI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown significant revenue growth in the latest quarter, its negative net income, declining gross margin, and bearish technical indicators suggest caution. Additionally, there are no significant positive catalysts or trading signals to support an immediate buy decision.

Technical Analysis

The technical indicators for ASPI are bearish. The MACD histogram is negative and contracting, the RSI is neutral at 40.015, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 4.554, with support at 4.052 and resistance at 5.057.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
3

Positive Catalysts

  • The company reported a 349.53% YoY increase in revenue for Q3 2025, which is a strong growth indicator.

Neutral/Negative Catalysts

  • Gross margin dropped significantly by -68.00% YoY, and net income remains negative at -$12.87 million. The stock has a bearish technical setup and no recent news or significant trading trends to act as a catalyst.

Financial Performance

In Q3 2025, revenue increased by 349.53% YoY to $4,889,526. However, net income remains negative at -$12,874,007 (up 77.05% YoY), and EPS improved to -0.15 (up 25.00% YoY). Gross margin dropped significantly to 8.65%, down -68.00% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for ASPI.

Wall Street analysts forecast ASPI stock price to rise
2 Analyst Rating
Wall Street analysts forecast ASPI stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 4.110
sliders
Low
11
Averages
12
High
13
Current: 4.110
sliders
Low
11
Averages
12
High
13
Cantor Fitzgerald
Derek Soderberg
Overweight
initiated
$13
AI Analysis
2025-12-04
Reason
Cantor Fitzgerald
Derek Soderberg
Price Target
$13
AI Analysis
2025-12-04
initiated
Overweight
Reason
Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes (ASPI) with an Overweight rating and $13 price target. ASP Isotopes has developed advanced isotope-enrichment technology that produces high-value nuclear fuel, medical isotopes, and silicon-28, and currently stands as the sole commercial-scale provider of certain isotopes, the analyst tells investors in a research note. The pending acquisition of Renergen (RGNNF) could give ASPI control of the world's largest high-concentration helium deposit, while the planned spinout of its quantum laser enrichment technology represents a near-term value-creation opportunity, Cantor says.
Cantor Fitzgerald
Derek Soderberg
initiated
$13
2025-12-04
Reason
Cantor Fitzgerald
Derek Soderberg
Price Target
$13
2025-12-04
initiated
Reason
Cantor Fitzgerald analyst Derek Soderberg initiated coverage of ASP Isotopes with an Overweight rating and $13 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ASPI
Unlock Now

People Also Watch